Friday, April 29, 2011 4:27 AM
|
Venöse Multiple Sklerose, CVI & SVI, CCSVI
via Kathleen Lynch: I'm really asking for it from the "organized social media monitors" at Big Pharma. You've all got my back, right? --- Cafepharma Message Board---: “BG12 will be the oral MS drug of choice. Gilenya will fail Novartis....Biogen owns MS. BG12 will get priority review and be available soon” http://www.cafepharma.com/boards/showthread.php?t=463797
|